CJC-1295 DAC 5 mg

Buy CJC-1295 DAC 5 mg – Long-Acting Growth Hormone Releasing Hormone (GHRH)

Dragon Pharma CJC-1295 DAC is a long-acting GHRH analog peptide designed to enhance the natural release of growth hormone (GH) in the body. With the addition of Drug Affinity Complex (DAC), CJC-1295 remains active for several days, promoting consistent GH and IGF-1 elevation for anti-aging, fat loss, lean muscle gain, and recovery benefits.

What Is CJC-1295 DAC?

CJC-1295 DAC is a synthetic peptide analog of GHRH (Growth Hormone Releasing Hormone). Unlike standard GHRH peptides, it is bound to a Drug Affinity Complex that significantly extends its half-life—up to 6–8 days—allowing weekly or bi-weekly dosing instead of multiple daily injections.

According to a clinical study published in The Journal of Clinical Endocrinology & Metabolism, CJC-1295 significantly increased GH and IGF-1 levels without affecting cortisol or prolactin, making it a safe and targeted option for GH therapy research.

Benefits of Dragon Pharma CJC-1295 DAC

• Promotes sustained growth hormone and IGF-1 release
• Enhances fat metabolism and supports lean mass retention
• Improves sleep quality, cellular repair, and recovery
• Supports anti-aging and cognitive health via HGH axis
• Weekly dosing due to extended half-life with DAC

How to Use CJC-1295 DAC

Each 5 mg vial of CJC-1295 DAC by Dragon Pharma is lyophilized and should be reconstituted with bacteriostatic water. Typical research dosing protocols involve injecting 1 to 2 mg once or twice weekly subcutaneously or intramuscularly. This provides stable GH release without the pulsatile effects seen in other GHRH peptides.

To maximize effects, researchers often stack it with synergistic compounds like BPC-157, GHK-Cu, or AOD 9604 depending on the goal (fat loss, repair, anti-aging).

Who Uses CJC-1295 DAC in Research?

• Anti-aging researchers studying natural HGH elevation
• Sports scientists examining body composition improvements
• Biohackers exploring peptides for sleep and cognitive function
• Physicians studying IGF-1 modulation in longevity protocols

Legal Status & Research Use

CJC-1295 DAC is not FDA-approved for human consumption but is legal to obtain for research purposes in the United States. To ensure authenticity, order through a trusted supplier of Dragon Pharma CJC-1295 DAC.

Peptide Stacking Recommendations

Dragon Pharma's CJC-1295 DAC can be part of multi-targeted peptide stacks:

• Melanotan 2 – for libido and mood enhancement
• PT-141 – for sexual health support during GH cycles
• Cut Long 300 – injectable support in recomposition cycles

Side Effects and Safety

CJC-1295 DAC is well-tolerated when used in appropriate research doses. Some subjects may experience mild water retention, flushing, or fatigue. Rarely, injection site irritation can occur. It does not stimulate prolactin or cortisol, unlike some growth hormone secretagogues.

Why Choose Dragon Pharma?

With extensive lab-testing, reliable dosing, and high-purity peptides, Dragon Pharma stands out in the peptide research market. The CJC-1295 DAC formula is carefully manufactured to preserve the integrity of the DAC modification, ensuring extended GH stimulation with minimal injections. Explore more options in the Dragon Pharma peptide catalog.

Frequently Asked Questions